1 | 313397-13-6 | Reversan | Reversan | C26H27N5O2
| | |
2 | 700874-71-1 | 4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1,2-b]吡唑-3-基]-7-[2-(4-吗啉基)乙氧基]喹啉 | LY2109761 | C26H27N5O2
| 活性分子;小分子抑制剂;细胞生物学试剂;信号转导通路激酶抑制剂;小分子抑制剂,天然产物 | |
3 | 163521-12-8 | 维拉佐酮 | Vilazodone | C26H27N5O2
| 原料药;医药原料;化学试剂;医药中间体;小分子抑制剂;G蛋白偶联受体&G蛋白 | |
4 | | 4-[(1-benzhydryl-1H-tetraazol-5-yl)(4-methoxyphenyl)methyl]morpholine | 4-[(1-benzhydryl-1H-tetraazol-5-yl)(4-methoxyphenyl)methyl]morpholine | C26H27N5O2
| | |
5 | | 1-PHENOXY-3-[4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZIN-1-YL]PROPAN-2-OL | 1-PHENOXY-3-[4-(8-PYRIMIDIN-5-YLQUINOLIN-2-YL)PIPERAZIN-1-YL]PROPAN-2-OL | C26H27N5O2
| | |
6 | | (1-BENZYL-1H-BENZOIMIDAZOL-2-YL)-[1-(4-NITRO-BENZYL)-PIPERIDIN-4-YL]-AMINE | (1-BENZYL-1H-BENZOIMIDAZOL-2-YL)-[1-(4-NITRO-BENZYL)-PIPERIDIN-4-YL]-AMINE | C26H27N5O2
| | |
7 | | (5-(4-ETHOXYPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-2-YL)(4-PHENYLPIPERAZIN-1-YL)METHANONE | (5-(4-ETHOXYPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-2-YL)(4-PHENYLPIPERAZIN-1-YL)METHANONE | C26H27N5O2
| | |
8 | 2494198-61-5 | 4-Quinazolinamine, 7-methoxy-N-[(3-methoxyphenyl)methyl]-2-[3-(3-pyridinyl)-1-pyrrolidinyl]- | 4-Quinazolinamine, 7-methoxy-N-[(3-methoxyphenyl)methyl]-2-[3-(3-pyridinyl)-1-pyrrolidinyl]- | C26H27N5O2
| | |
9 | 471884-70-5 | 2-[3-(dimethylamino)phenoxy]-N'-{[2,5-dimethyl-1-(6-quinolinyl)-1H-pyrrol-3-yl]methylene}acetohydrazide | 2-[3-(dimethylamino)phenoxy]-N'-{[2,5-dimethyl-1-(6-quinolinyl)-1H-pyrrol-3-yl]methylene}acetohydrazide | C26H27N5O2
| | |
10 | | 1-benzyl-N-cyclohexyl-2-imino-10-methyl-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2,3-d]pyrimidine-3-carboxamide | 1-benzyl-N-cyclohexyl-2-imino-10-methyl-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2,3-d]pyrimidine-3-carboxamide | C26H27N5O2
| | |
11 | 421551-99-7 | 4-((((1H-benzo[d]iMidazole-2-yl)Methyl)(5,6,7,8-tetrahydroquinolin-8-yl)aMino)Methyl)-3-(aMinoMethyl)benzoic acid | 4-((((1H-benzo[d]iMidazole-2-yl)Methyl)(5,6,7,8-tetrahydroquinolin-8-yl)aMino)Methyl)-3-(aMinoMethyl)benzoic acid | C26H27N5O2
| | |